MX2019000903A - Metodos para purificar proteinas que contienen fc. - Google Patents
Metodos para purificar proteinas que contienen fc.Info
- Publication number
- MX2019000903A MX2019000903A MX2019000903A MX2019000903A MX2019000903A MX 2019000903 A MX2019000903 A MX 2019000903A MX 2019000903 A MX2019000903 A MX 2019000903A MX 2019000903 A MX2019000903 A MX 2019000903A MX 2019000903 A MX2019000903 A MX 2019000903A
- Authority
- MX
- Mexico
- Prior art keywords
- protein
- methods
- purifying
- resin
- elution buffer
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/14—Extraction; Separation; Purification
- C07K1/16—Extraction; Separation; Purification by chromatography
- C07K1/22—Affinity chromatography or related techniques based upon selective absorption processes
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
- B01D15/08—Selective adsorption, e.g. chromatography
- B01D15/26—Selective adsorption, e.g. chromatography characterised by the separation mechanism
- B01D15/34—Size-selective separation, e.g. size-exclusion chromatography; Gel filtration; Permeation
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
- B01D15/08—Selective adsorption, e.g. chromatography
- B01D15/26—Selective adsorption, e.g. chromatography characterised by the separation mechanism
- B01D15/38—Selective adsorption, e.g. chromatography characterised by the separation mechanism involving specific interaction not covered by one or more of groups B01D15/265 and B01D15/30 - B01D15/36, e.g. affinity, ligand exchange or chiral chromatography
- B01D15/3804—Affinity chromatography
- B01D15/3809—Affinity chromatography of the antigen-antibody type, e.g. protein A, G or L chromatography
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
- B01D15/08—Selective adsorption, e.g. chromatography
- B01D15/42—Selective adsorption, e.g. chromatography characterised by the development mode, e.g. by displacement or by elution
- B01D15/424—Elution mode
- B01D15/426—Specific type of solvent
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/14—Extraction; Separation; Purification
- C07K1/34—Extraction; Separation; Purification by filtration, ultrafiltration or reverse osmosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
- C07K16/06—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies from serum
- C07K16/065—Purification, fragmentation
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
- C07K2317/31—Immunoglobulins specific features characterized by aspects of specificity or valency multispecific
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
- C07K2317/35—Valency
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/60—Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/60—Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments
- C07K2317/62—Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments comprising only variable region components
- C07K2317/622—Single chain antibody (scFv)
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Analytical Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Molecular Biology (AREA)
- Medicinal Chemistry (AREA)
- Genetics & Genomics (AREA)
- General Health & Medical Sciences (AREA)
- Biophysics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biochemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Water Supply & Treatment (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Storage Device Security (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201662365943P | 2016-07-22 | 2016-07-22 | |
| PCT/US2017/043384 WO2018018011A2 (en) | 2016-07-22 | 2017-07-21 | Methods of purifying fc-containing proteins |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2019000903A true MX2019000903A (es) | 2019-05-15 |
Family
ID=59656168
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2019000903A MX2019000903A (es) | 2016-07-22 | 2017-07-21 | Metodos para purificar proteinas que contienen fc. |
| MX2023006291A MX2023006291A (es) | 2016-07-22 | 2019-01-21 | Metodos para purificar proteinas que contienen fc. |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2023006291A MX2023006291A (es) | 2016-07-22 | 2019-01-21 | Metodos para purificar proteinas que contienen fc. |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US11312745B2 (https=) |
| EP (1) | EP3487867B1 (https=) |
| JP (2) | JP7092744B2 (https=) |
| KR (2) | KR102579850B1 (https=) |
| CN (2) | CN109563125B (https=) |
| AU (2) | AU2017298984B2 (https=) |
| CA (2) | CA3218290A1 (https=) |
| IL (2) | IL285146B (https=) |
| MA (1) | MA45721A (https=) |
| MX (2) | MX2019000903A (https=) |
| SG (1) | SG11201900573UA (https=) |
| WO (1) | WO2018018011A2 (https=) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN112839959A (zh) * | 2018-09-21 | 2021-05-25 | 特尼奥生物股份有限公司 | 用于纯化异源二聚多特异性抗体的方法 |
| AU2019356564A1 (en) * | 2018-10-11 | 2021-04-29 | Amgen Inc. | Downstream processing of bispecific antibody constructs |
| CA3123052A1 (en) * | 2019-01-16 | 2020-07-23 | Regeneron Pharmaceuticals, Inc. | Method and system of identifying and quantifying antibody fragmentation |
| KR102286892B1 (ko) * | 2019-07-08 | 2021-08-06 | 삼천당제약주식회사 | 안과용 단백질 제제의 정제방법 |
| CN110724204B (zh) * | 2019-11-18 | 2021-10-22 | 广东菲鹏制药股份有限公司 | Fc融合蛋白的纯化方法 |
| CN112881675A (zh) * | 2019-11-29 | 2021-06-01 | 广东菲鹏生物有限公司 | IgM抗体检测稀释液 |
| BR112022019841A2 (pt) | 2020-04-09 | 2022-12-06 | Cytomx Therapeutics Inc | Composições contendo anticorpos ativáveis |
| EP4213958B1 (en) * | 2020-09-16 | 2026-02-18 | Waters Technologies Corporation | Improved size exclusion chromatography utilizing low concentration amino acids in size exclusion chromatography mobile phase |
| CN118414350A (zh) * | 2021-10-19 | 2024-07-30 | 阿特根公司 | 纯化具有igg fc结构域的融合蛋白的方法 |
| CN113980092B (zh) * | 2021-12-09 | 2024-05-14 | 上海药明生物技术有限公司 | 一种蛋白质亲和纯化方法 |
| CN116165290B (zh) * | 2021-12-17 | 2025-06-27 | 复旦大学 | 一种抗体药物研发流程中工程细胞株的筛选方法 |
| CN116271982B (zh) * | 2022-11-30 | 2024-01-09 | 杭州广科安德生物科技有限公司 | 一种血液高丰度蛋白免疫亲和柱的再生方法 |
Family Cites Families (45)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4968607A (en) | 1987-11-25 | 1990-11-06 | Immunex Corporation | Interleukin-1 receptors |
| GB8823869D0 (en) | 1988-10-12 | 1988-11-16 | Medical Res Council | Production of antibodies |
| WO1990005183A1 (en) | 1988-10-31 | 1990-05-17 | Immunex Corporation | Interleukin-4 receptors |
| US5530101A (en) | 1988-12-28 | 1996-06-25 | Protein Design Labs, Inc. | Humanized immunoglobulins |
| US6713610B1 (en) | 1990-01-12 | 2004-03-30 | Raju Kucherlapati | Human antibodies derived from immunized xenomice |
| EP1690934A3 (en) | 1990-01-12 | 2008-07-30 | Abgenix, Inc. | Generation of xenogeneic antibodies |
| US6673986B1 (en) | 1990-01-12 | 2004-01-06 | Abgenix, Inc. | Generation of xenogeneic antibodies |
| US5427908A (en) | 1990-05-01 | 1995-06-27 | Affymax Technologies N.V. | Recombinant library screening methods |
| AU651596B2 (en) | 1990-06-05 | 1994-07-28 | Immunex Corporation | Type II interleukin-1 receptors |
| US5350683A (en) | 1990-06-05 | 1994-09-27 | Immunex Corporation | DNA encoding type II interleukin-1 receptors |
| GB9015198D0 (en) | 1990-07-10 | 1990-08-29 | Brien Caroline J O | Binding substance |
| US5874299A (en) | 1990-08-29 | 1999-02-23 | Genpharm International, Inc. | Transgenic non-human animals capable of producing heterologous antibodies |
| US6300129B1 (en) | 1990-08-29 | 2001-10-09 | Genpharm International | Transgenic non-human animals for producing heterologous antibodies |
| US5877397A (en) | 1990-08-29 | 1999-03-02 | Genpharm International Inc. | Transgenic non-human animals capable of producing heterologous antibodies of various isotypes |
| US5545806A (en) | 1990-08-29 | 1996-08-13 | Genpharm International, Inc. | Ransgenic non-human animals for producing heterologous antibodies |
| ATE300615T1 (de) | 1990-08-29 | 2005-08-15 | Genpharm Int | Transgene mäuse fähig zur produktion heterologer antikörper |
| US6255458B1 (en) | 1990-08-29 | 2001-07-03 | Genpharm International | High affinity human antibodies and human antibodies against digoxin |
| NZ255101A (en) | 1992-07-24 | 1997-08-22 | Cell Genesys Inc | A yeast artificial chromosome (yac) vector containing an hprt minigene expressible in murine stem cells and genetically modified rodent therefor |
| US5731168A (en) | 1995-03-01 | 1998-03-24 | Genentech, Inc. | Method for making heteromultimeric polypeptides |
| US6130364A (en) | 1995-03-29 | 2000-10-10 | Abgenix, Inc. | Production of antibodies using Cre-mediated site-specific recombination |
| CA2219361C (en) | 1995-04-27 | 2012-02-28 | Abgenix, Inc. | Human antibodies derived from immunized xenomice |
| EP1500329B1 (en) | 1996-12-03 | 2012-03-21 | Amgen Fremont Inc. | Human antibodies that specifically bind human TNF alpha |
| US6271349B1 (en) | 1996-12-23 | 2001-08-07 | Immunex Corporation | Receptor activator of NF-κB |
| WO1999053059A1 (en) * | 1998-04-16 | 1999-10-21 | Genentech, Inc. | Secretion of glycosylated proteins using a tissue plasminogen activator pro-sequence |
| US6660843B1 (en) | 1998-10-23 | 2003-12-09 | Amgen Inc. | Modified peptides as therapeutic agents |
| US20030133939A1 (en) | 2001-01-17 | 2003-07-17 | Genecraft, Inc. | Binding domain-immunoglobulin fusion proteins |
| JP5553963B2 (ja) * | 2004-10-22 | 2014-07-23 | アムジエン・インコーポレーテツド | 組換え抗体をリフォールディングする方法 |
| TWI372763B (en) * | 2005-06-17 | 2012-09-21 | Wyeth Llc | Methods of purifying anti a beta antibodies |
| WO2007081906A2 (en) * | 2006-01-06 | 2007-07-19 | Amgen Inc. | Purification by column-chromatography using eluants containing organic solvents |
| WO2007146968A2 (en) | 2006-06-12 | 2007-12-21 | Trubion Pharmaceuticals, Inc. | Single-chain multivalent binding proteins with effector function |
| US10982250B2 (en) * | 2006-09-18 | 2021-04-20 | Genentech, Inc. | Methods of protein production |
| US8198409B2 (en) * | 2007-05-21 | 2012-06-12 | Nomadic Bioscience Co., Ltd. | Polypeptide, an affinity chromatography material, and a method for separating and/or purifying immunoglobulin |
| ES2563027T3 (es) | 2008-01-07 | 2016-03-10 | Amgen Inc. | Método para fabricación de moléculas heterodímeras Fc de anticuerpos utilizando efectos de conducción electrostática |
| EP2321338A1 (en) * | 2008-08-14 | 2011-05-18 | Merck Sharp & Dohme Corp. | Methods for purifying antibodies using protein a affinity chromatography |
| EA020621B1 (ru) * | 2009-06-22 | 2014-12-30 | Амген Инк. | Рефолдинг белков с использованием химически контролируемого окислительно-восстановительного состояния |
| LT3660032T (lt) * | 2009-06-25 | 2026-02-25 | Amgen Inc. | Ne žinduolių sistemoje ekspresuotų baltymų surišamojo gryninimo būdai |
| KR20120108967A (ko) | 2009-09-16 | 2012-10-05 | 제넨테크, 인크. | 코일드 코일 및/또는 테더 함유 단백질 복합체 및 그의 용도 |
| CN102382190B (zh) * | 2010-09-01 | 2014-04-09 | 山东新时代药业有限公司 | 分离和去除TNFR-Fc融合蛋白中寡聚体的方法 |
| US20130317172A1 (en) | 2010-12-24 | 2013-11-28 | Nomadic Bioscience Co., Ltd. | Method for immobilizing temperature responsive protein a |
| BR112014000352A2 (pt) * | 2011-07-08 | 2017-02-14 | Merck Sharp & Dohe Corp | método de purificar uma proteína de fusão-fc, proteínas de fusão contendo fc purificada, tnfr:fc purificada, e tnfr:fc elevadamente purificada |
| US10189891B2 (en) * | 2012-03-28 | 2019-01-29 | Ge Healthcare Bioprocess R&D Ab | Affinity chromatography matrix |
| EP2889617B1 (en) | 2012-08-27 | 2017-10-11 | Asahi Kasei Medical Co., Ltd. | Antibody purification method by means of temperature-responsive chromatography |
| UY35148A (es) * | 2012-11-21 | 2014-05-30 | Amgen Inc | Immunoglobulinas heterodiméricas |
| US20140302037A1 (en) | 2013-03-15 | 2014-10-09 | Amgen Inc. | BISPECIFIC-Fc MOLECULES |
| CN110627907B (zh) * | 2013-11-04 | 2024-03-29 | 艾科诺斯科技股份有限公司 | 重靶向t细胞的异源二聚免疫球蛋白的产生 |
-
2017
- 2017-07-21 CA CA3218290A patent/CA3218290A1/en active Pending
- 2017-07-21 KR KR1020227028721A patent/KR102579850B1/ko active Active
- 2017-07-21 MX MX2019000903A patent/MX2019000903A/es unknown
- 2017-07-21 KR KR1020197003162A patent/KR102435801B1/ko active Active
- 2017-07-21 JP JP2019503247A patent/JP7092744B2/ja active Active
- 2017-07-21 SG SG11201900573UA patent/SG11201900573UA/en unknown
- 2017-07-21 EP EP17754514.2A patent/EP3487867B1/en active Active
- 2017-07-21 CN CN201780045463.1A patent/CN109563125B/zh active Active
- 2017-07-21 MA MA045721A patent/MA45721A/fr unknown
- 2017-07-21 AU AU2017298984A patent/AU2017298984B2/en active Active
- 2017-07-21 WO PCT/US2017/043384 patent/WO2018018011A2/en not_active Ceased
- 2017-07-21 US US16/093,994 patent/US11312745B2/en active Active
- 2017-07-21 CA CA3031469A patent/CA3031469C/en active Active
- 2017-07-21 IL IL285146A patent/IL285146B/en unknown
- 2017-07-21 CN CN202210979746.6A patent/CN115925780B/zh active Active
-
2019
- 2019-01-21 MX MX2023006291A patent/MX2023006291A/es unknown
- 2019-01-21 IL IL264375A patent/IL264375B/en unknown
-
2022
- 2022-06-15 JP JP2022096278A patent/JP7411020B2/ja active Active
-
2023
- 2023-08-31 AU AU2023222915A patent/AU2023222915B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| AU2023222915B2 (en) | 2026-01-22 |
| KR102579850B1 (ko) | 2023-09-18 |
| CN115925780A (zh) | 2023-04-07 |
| CA3218290A1 (en) | 2018-01-25 |
| IL264375A (en) | 2019-02-28 |
| KR102435801B1 (ko) | 2022-08-25 |
| CN109563125A (zh) | 2019-04-02 |
| MX2023006291A (es) | 2023-06-13 |
| SG11201900573UA (en) | 2019-02-27 |
| CA3031469C (en) | 2025-11-18 |
| WO2018018011A3 (en) | 2018-03-01 |
| MA45721A (fr) | 2019-05-29 |
| JP7411020B2 (ja) | 2024-01-10 |
| CA3031469A1 (en) | 2018-01-25 |
| IL285146A (en) | 2021-08-31 |
| EP3487867A2 (en) | 2019-05-29 |
| KR20190037247A (ko) | 2019-04-05 |
| US11312745B2 (en) | 2022-04-26 |
| AU2023222915A1 (en) | 2023-09-21 |
| EP3487867B1 (en) | 2026-04-01 |
| IL264375B (en) | 2021-09-30 |
| US20190127418A1 (en) | 2019-05-02 |
| AU2017298984B2 (en) | 2023-08-31 |
| WO2018018011A2 (en) | 2018-01-25 |
| JP2022120138A (ja) | 2022-08-17 |
| CN109563125B (zh) | 2022-08-09 |
| AU2017298984A1 (en) | 2019-02-07 |
| CN115925780B (zh) | 2025-11-04 |
| JP2019528255A (ja) | 2019-10-10 |
| IL285146B (en) | 2022-09-01 |
| KR20220120716A (ko) | 2022-08-30 |
| JP7092744B2 (ja) | 2022-06-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX2019000903A (es) | Metodos para purificar proteinas que contienen fc. | |
| WO2013177115A3 (en) | Novel purification of human, humanized, or chimeric antibodies using protein a affinity chromatography | |
| PE20221791A1 (es) | Composiciones de proteina anti-vegf y metodos para producir la misma | |
| WO2006012415A3 (en) | Rage protein derivatives | |
| JP2016530533A5 (https=) | ||
| MX2015005178A (es) | Purificacion de polipeptidos usando ultrafiltracion de flujo tangencial de etapa doble. | |
| EA200970231A1 (ru) | СПОСОБ ОЧИСТКИ Fc-СОДЕРЖАЩИХ БЕЛКОВ | |
| KR20160044023A (ko) | 히드록시아파타이트 크로마토그래피를 사용하는 이중특이적 항체 및 이중특이적 항체 생산 부산물의 분리 | |
| WO2020226502A9 (en) | Variant domains for multimerizing proteins and separation thereof | |
| MX2020000288A (es) | Cromatografia. | |
| US20250340589A1 (en) | Purifying antibodies | |
| MX340772B (es) | Medios y metodos para fabricar neurotoxina altamente pura. | |
| KR20220079910A (ko) | 숙주-세포 단백질을 특성화하는 방법 | |
| MX2018005831A (es) | Gradientes de ph-sal opuestos para separaciones de proteina mejoradas. | |
| JP2016529489A5 (https=) | ||
| WO2009028531A1 (ja) | ドックリンポリペプチドおよびそれを利用した組換え融合タンパク質の精製方法 | |
| JP2017514803A (ja) | ゴナドトロピンの新規の精製方法 | |
| JP6574033B2 (ja) | Ｗｎｔ蛋白質の製造方法および保存方法 | |
| Chu et al. | Purification of polyclonal immunoglobulin G from human serum using peptide‐based adsorbents | |
| Urtasun et al. | Triazinic dye ligand selection by surface plasmon resonance for recombinant lactoferricin purification | |
| ZA202002083B (en) | Antibody purification | |
| US20250188120A1 (en) | Affinity chromatographic production of clinical human igg products | |
| RU2683549C1 (ru) | СИСТЕМА ДЛЯ ЭКСПРЕССИИ FAB-ФРАГМЕНТОВ АНТИТЕЛ В МЕТИЛОТРОФНЫХ ДРОЖЖАХ PICHIAPASTORIS, НА ОСНОВЕ РЕКОМБИНАНТНЫХ ПЛАЗМИДНЫХ ДНК Ab-HCh-HIS/pPICZ_α_A И Ab-LCh-LAMBDA/pPICZα_A, ПРЕДНАЗНАЧЕННЫХ ДЛЯ КЛОНИРОВАНИЯ ВАРИАБЕЛЬНЫХ ДОМЕНОВ ТЯЖЕЛОЙ И ЛЕГКОЙ ЦЕПЕЙ АНТИТЕЛ, СООТВЕТСТВЕННО | |
| MX2016002188A (es) | Composición farmacéutica de proteínas híbridas recombinantes capaces de generar anticuerpos neutralizantes en contra del veneno de alacranes. | |
| WO2013125936A3 (es) | Prueba de diagnóstico para enfermedades infecciosas en ganado bovino |